Prevention of Venous Thromboembolism after Hospital Discharge Continued Pharmacological Prophylaxis versus No Prophylaxis in Patients Undergoing Total Hip Replacement (original) (raw)

Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty

B. Levitan

Vascular Health and Risk Management, 2014

View PDFchevron_right

Venous Thromboembolism Prophylaxis: Need for Continuous Assessment Due to Changes in Risk During the Same Hospitalization

thomas kingsley

Mayo Clinic Proceedings: Innovations, Quality & Outcomes, 2020

View PDFchevron_right

Impact of venous thromboembolism on clinical management and therapy after hip and knee arthroplasty

William Fisher

Canadian Journal of Surgery, 2011

View PDFchevron_right

Asia-Pacific venous thromboembolism consensus in knee and hip arthroplasty and hip fracture surgery: Part 2. Mechanical venous thromboembolism prophylaxis

Ngai Nung Lo

Knee Surgery & Related Research, 2021

View PDFchevron_right

Pharmacologic Prophylaxis for Venous Thromboembolism Among Patients With Total Joint Replacement

Daniel Nisi

American Journal of Therapeutics, 2016

View PDFchevron_right

Comparative study of extended versus short term thromboprophylaxis in patients undergoing elective total hip and knee arthroplasty in Indian population

Ratheesh Kumar

Indian Journal of Orthopaedics, 2013

View PDFchevron_right

Bleeding and thromboembolism risk of standard antithrombotic prophylaxis after hip or knee replacement within an enhanced recovery program

aymard de ladoucette

Orthopaedics & Traumatology: Surgery & Research, 2020

View PDFchevron_right

A review of the evidence for and against thromboprophylaxis in total hip replacement

Mahiben Maruthappu

Acta orthopaedica Belgica

View PDFchevron_right

Evaluating the effectiveness of using enoxaparin to prevent venous thromboembolism in hip replacement patients: A retrospective cohort study

Dong Kha

Biomedical Research and Therapy, 2021

View PDFchevron_right

Prevention of venous thromboembolism after major orthopedic surgery: summing up evidence about old and new antithrombotic agents

Henri Bounameaux

Journal of Thrombosis and Haemostasis, 2004

View PDFchevron_right

Impact of thromboprophylaxis guidelines on clinical outcomes following total hip and total knee replacement

Henry Henk, Rita Selby

Thrombosis research, 2012

View PDFchevron_right

Cost-Effectiveness of Venous Thromboembolism Prophylaxis after Total Hip Replacement

Juan Arcelus

Phlebology, 2002

View PDFchevron_right

Postdischarge thromboprophylaxis and mortality risk after hip-or knee-replacement surgery

hacene nedjar

Canadian Medical Association Journal, 2008

View PDFchevron_right

Venous thromboembolism in 13 Indonesian patients undergoing major orthopedic surgery

Ifran Saleh

Medical Journal of Indonesia, 2009

View PDFchevron_right

Venous thromboprophylaxis in general surgery ward admissions: strategies for improvement

M. Milberg

International Journal for Quality in Health Care, 2012

View PDFchevron_right

Low dose compared to variable dose Warfarin and to Fondaparinux as prophylaxis for thromboembolism after elective hip or knee replacement surgery; a randomized, prospective study

Laura Hou

Thrombosis Journal, 2015

View PDFchevron_right

Thromboprophylaxis and death after total hip replacement

Sophia Kunze

The Journal of Bone and Joint Surgery, 1996

View PDFchevron_right

Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients

ANA THEREZA ROCHA

Vascular Health and …, 2007

View PDFchevron_right

Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement

Agg Turpie

The Journal of Bone and Joint Surgery. British volume, 2009

View PDFchevron_right

Oral thromboprophylaxis following total hip replacement: the issue of compliance

C. Vielpeau

Orthopaedics & traumatology, surgery & research : OTSR, 2012

View PDFchevron_right

Economics of Thromboprophylaxis in Total Hip Replacement Surgery

Jeff Harrison

PharmacoEconomics, 1997

View PDFchevron_right

The influence of oral anticoagulation therapy on deep vein thrombosis rates four weeks after total hip replacement

jose reyna

Journal of Vascular Surgery, 1999

View PDFchevron_right

A Review of the Preventive Strategies for Venous Thromboembolism in Hospitalized Patients

Heritage Kristilere

Cureus, 2023

View PDFchevron_right

Safe practice for patients receiving anticoagulant therapy

Jane Harden

Nursing Standard, 2010

View PDFchevron_right

Compliance of dutch orthopedic departments with national guidelines on thromboprophylaxis

Harmen Ettema

Acta Orthopaedica, 2005

View PDFchevron_right

Venous Thromboembolic Disease After Hip Surgery

Samuel Berkman

Clinical Orthopaedics and Related Research, 1989

View PDFchevron_right

Venous Thromboembolism (VTE) Prophylaxis for Hip and Knee Arthroplasty: Changing Trends

Nadia Nastassia Ifran

Current Reviews in Musculoskeletal Medicine, 2014

View PDFchevron_right

Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis

Henri Bounameaux

Thrombosis and haemostasis, 2002

View PDFchevron_right